Skip to content

GoodRx Holdings, Inc. GDRX Payments For Software

Payments For Software at other companies

Hims & Hers Health logo
Hims & Hers HealthHIMS
$6.48M+74.6%

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$911.04M-44.5%
Enterprise value$1.22B-35.4%
P/E44.3×-13.4×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForSoftware.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s payments for software.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s payments for software?
GoodRx Holdings, Inc. (GDRX) reported payments for software of $20.51M in Q1 2026.
How has GoodRx Holdings, Inc.'s payments for software changed year-over-year?
GoodRx Holdings, Inc.'s payments for software decreased by 5.6% year-over-year, from $21.73M to $20.51M.
What is the long-term trend for GoodRx Holdings, Inc.'s payments for software?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s payments for software has grown at a 23.9% compound annual growth rate (CAGR), from $29.89M to $70.5M.
What does payments for software mean?
This represents cash outflows dedicated to the acquisition or development of internal-use software and digital platforms. For technology-driven companies, this is a critical measure of capital expenditure directed toward maintaining and enhancing the core product infrastructure.